Kayo Ibaragi

Affiliations

KM Biologics Co., Ltd. (KM Biologics), Kumamoto, Japan.

Publications (1)

Clinical phase II and III studies of an AS03-adjuvanted H5N1 influenza vaccine produced in an EB66

Influenza and other respiratory viruses

Avec: Masafumi Endo , Mitsuyoshi Tanishima , Kayo Ibaragi , Kenshi Hayashida , Tadashi Fukuda , Tetsuro Tanabe , Takeshi Naruse , Yoichiro Kino , Kohji Ueda

Réseau de co-auteurs

Masafumi Endo 1 collaboration

Mitsuyoshi Tanishima 1 collaboration

Kenshi Hayashida 1 collaboration

Tadashi Fukuda 1 collaboration

Tetsuro Tanabe 1 collaboration

Takeshi Naruse 1 collaboration

Yoichiro Kino 1 collaboration

Kohji Ueda 1 collaboration